Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
9.24
+0.05 (0.54%)
At close: Aug 10, 2026, 4:00 PM EDT
9.25
+0.01 (0.11%)
After-hours: Aug 10, 2026, 5:42 PM EDT

Ocular Therapeutix Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
---195.81102.3164.16
Cash & Short-Term Investments
---195.81102.3164.16
Cash Growth
---91.41%-37.68%-28.02%
Accounts Receivable
30.2630.6532.3926.1821.3321.14
Inventory
3.833.563.042.311.971.25
Other Current Assets
11.710.8613.467.944.034.75
Total Current Assets
644.43782.13440.99232.24129.63191.3
Net Property, Plant & Equipment
25.2824.3115.3318.2117.911.82
Other Long-Term Assets
1.611.611.611.611.761.76
Total Assets
671.32808.06457.94252.06149.29204.89
Accounts Payable
74.154.184.395.124.59
Accrued Expenses
39.0643.8435.1228.6724.120.12
Current Portion of Leases
3.122.821.931.591.61.62
Unearned Revenue
--0.130.260.58-
Total Current Liabilities
49.1750.8141.3534.931.426.34
Long-Term Debt
72.871.3468.5174.9354.0151.44
Long-Term Leases
3.472.825.356.888.685.92
Other Long-Term Liabilities
25.8428.7927.3944.2319.8333.19
Total Long-Term Liabilities
102.1102.94101.24126.0382.5290.55
Total Liabilities
151.28153.75142.59160.93113.91116.89
Common Stock
0.020.020.020.010.010.01
Additional Paid-in Capital
1,8441,8111,206788.7652.21633.8
Retained Earnings
-1,324-1,157-891.08-697.58-616.84-545.8
Shareholders' Equity
520.04654.31315.3491.1335.3888
Total Liabilities & Equity
671.32808.06457.94252.06149.29204.89
Total Debt
79.3876.9775.7883.3964.2858.98
Net Cash (Debt)
-79.38-76.97-75.78112.4238.02105.18
Net Cash Growth
---195.70%-63.86%-37.99%
Net Cash Per Share
-0.37-0.41-0.481.310.461.28
Book Value
520.04654.31315.3491.1335.3888
Book Value Per Share
2.433.491.991.060.431.07
Tangible Book Value
520.04654.31315.3491.1335.3888
Tangible Book Value Per Share
2.433.491.991.060.431.07
SEC Filings: 10-K · 10-Q